Urgent Update – FDA Ends Semaglutide Shortage: What This Means for Med Spas
The FDA has officially declared an end to the shortage of semaglutide, the active ingredient in the popular medications Ozempic and Wegovy. This announcement signals a significant shift in how compounding pharmacies, medical spas, and other businesses can offer these...
The Corporate Transparency Act Is Back: What MedSpa Owners Need to Know
The Corporate Transparency Act (CTA) has been a hot topic in recent months, with a major legal challenge temporarily putting the law on hold. However, a federal appeals court has now reinstated the CTA, meaning businesses—including med spas—must comply with its...
Syndeo Hydrafacial Defects Spark Lawsuit: What Medspa Owners Need to Know
A class action lawsuit alleges that the popular Hydrafacial Syndeo machine suffers from serious design flaws, leaving spa owners frustrated and financially burdened. The lawsuit, filed in October 2024, claims that The Hydrafacial Company and its parent company, The...
Pfizer’s $60M Settlement: A Warning for MedSpa Owners on Physician Payments
A recent $60 million settlement involving Pfizer is a wake-up call for healthcare businesses—including MedSpas—about the risks of improper payments to physicians. The U.S. Department of Justice (DOJ) found that Pfizer paid doctors in ways that violated federal laws,...